Merck and Co

Merck & Co’s US antibiotic withdrawal sends the wrong signals for combating resistance Chemistry World Magazine09:17Antibiotic Resistance Pharma Global Health

Merck pulls antibiotic from US market Center for Infectious Disease Research and Policy22:20Antibiotic Resistance Pharma Global Health

Merck suffers a setback in Europe over its new Keytruda formulation STAT18:10Patent Law Intellectual Property Pharma

Merck’s new KEYTRUDA shot blocked in Europe after court loss (1) Bloomberg Law16:22Patent Law Intellectual Property Pharma

Merck says investigational skin therapy shows potential Benzinga19:34

2Merck Animal Health expands sensehub dairy monitoring AgriMarketing08:07

Vaxcyte's 31-strain pneumococcal vaccine met its main antibody goals against prevnar 20 and Capvaxive in Phase 3 trial Medical Daily03:45Pfizer Vaccine Pfizer Pharma

Vaxcyte claims success in bid to beat Pfizer and Merck in lucrative vaccine market STAT13:25Pfizer Vaccine Pfizer Pharma

Merck and Moderna have ‘lot of exploring to do’ after initial cancer vaccine success STAT21:03Moderna Vaccine Moderna mRNA

Merck suffers eight-country Keytruda SC sales ban in latest European cross-border injunction IAM15:07Pharma

Merck and Daiichi withdraw small cell lung cancer drug bid after FDA signals phase 2 data fell short Medical Daily17:14Lung Cancer FDA Cancer

Daiichi, Merck withdraw U.S. Filing for lung cancer drug ifinatamab deruxteca RTT News10:09Lung Cancer FDA Cancer

NICE backs first systemic therapy for desmoid tumours PharmaTimes11:59NICE Pharma

Ogsiveo recommended by NICE to treat rare soft tissue tumours PMLiVE11:10NICE Pharma

Pharmalittle: We’re reading about Novo licensing a Chinese obesity pill, Merck pulling an… STAT14:33Obesity China Pharma

AstraZeneca, Merck, Novo deals boost Chinese biotech as global interest grows South China Morning Post10:02Obesity China Pharma

Pharmalittle: We’re reading about GLP-1s becoming lifestyle drugs, a setback for Merck and… STAT14:17Cancer Treatment Pharma Cancer

Latest News

In the last 4 hours

Merck and Moderna have ‘lot of exploring to do’ after initial cancer vaccine success STAT21:03 15-Oct-26

In the last 8 hours

Changing Expectations, Empowering Girls: Dr. Rasha Kelej, Chief Executive Officer (CEO) of… African Press Organization17:53 15-Oct-26

Yesterday

Here is What to Know Beyond Why Merck & Co., Inc. (MRK) is a Trending Stock Zacks15:05 15-Oct-26

Adlai Nortye Partners With Lilly And Merck KGaA To Evaluate AN4035 Combination In Solid Tumors RTT News14:15 15-Oct-26

Adlai To Enter Clinical Trial Collaborations With Lilly, Merck KGaA To Explore Cetuximab With AN4035 RTT News12:33 15-Oct-26

In the last 7 days

Will Keytruda Continue to Aid Merck's Top Line in Q3 Earnings? Zacks16:58 14-Oct-26

Merck Foundation Chief Executive Officer (CEO), Dr. Rasha Kelej Shares Why She Stopped… African Press Organization13:42 14-Oct-26

Cocoa traceability pilot links physical authentication to digital passport ahead of EUDR New Food12:49 14-Oct-26

Merck Healthcare Korea names ex-Antengene exec Lee Dong-yeol medical affairs head Korea Biomedical Review02:08 14-Oct-26

Merck (MRK) Stock Could Be A Bargain As Its 120% Run Continues Simply Wall St16:07 13-Oct-26

Merck suffers eight-country Keytruda SC sales ban in latest European cross-border injunction IAM15:07 13-Oct-26

Paul J. Diaz Elected to Merck & Co., Inc., Rahway, N.J., USA Board of Directors Business Wire (Press Release)12:08 13-Oct-26

Merck Showcases First-Time Pivotal Phase 3 Results From Oncology Pipeline and Continued… Business Wire (Press Release)11:48 13-Oct-26

Merck Dme trispecific in shade of anti-VEGF, safety issue confirmed BioWorld20:56 12-Oct-26

Merck Foundation Chief Executive Officer (CEO), Dr. Rasha Kelej Highlights the Importance of… African Press Organization17:13 12-Oct-26

Wall Street Bulls Look Optimistic About Merck (MRK): Should You Buy? Zacks15:39 12-Oct-26

Pharma’s $500B patent problem will come in waves — not as a cliff BioPharma Dive15:15 12-Oct-26

Full Results Take Shine Off Merck’s Eye Drug Challenger Scrip Pharma Intelligence10:54 12-Oct-26

Merck & Co’s US antibiotic withdrawal sends the wrong signals for combating resistance Chemistry World Magazine09:17 12-Oct-26

2. Bundesliga Preview: SV Darmstadt 98 vs Energie Cottbus Bulinews16:05 9-Oct-26

In the last month

HALO Wins Court Order Blocking Merck's Keytruda SC in Europe Zacks18:54 8-Oct-26

As Part of her new Mentorship and Leadership Platform, Dr. Rasha Kelej, Merck Foundation CEO… African Press Organization15:03 8-Oct-26

Merck suffers a setback in Europe over its new Keytruda formulation STAT18:10 7-Oct-26

Merck’s New Keytruda Shot Blocked in Europe After Court Loss (1) Bloomberg Law16:22 7-Oct-26

Halozyme Wins Injunction Stopping Manufacture and Sale of Merck's Keytruda SC in Multiple… PR Newswire (Press Release)13:34 7-Oct-26

Tempus Announces Multi-Year Collaboration with Moderna and Merck Business Wire (Press Release)13:31 7-Oct-26

Vaxcyte's 31-Strain Pneumococcal Vaccine Met Its Main Antibody Goals Against Prevnar 20 and Capvaxive in Phase 3 Trial Medical Daily03:45 7-Oct-26

Will Drug Approvals Change Merck (MRK) Narrative Simply Wall St00:11 7-Oct-26

Merck (MRK) Beats Stock Market Upswing: What Investors Need to Know Zacks23:53 6-Oct-26

Merck Stock Down 7% in a Month: Is the Dip a Buying Opportunity? Zacks17:36 6-Oct-26

Vaxcyte claims success in bid to beat Pfizer and Merck in lucrative vaccine market STAT13:25 5-Oct-26

‘Landmark’ Moderna, Merck mRNA melanoma data headline August BioWorld22:21 2-Oct-26

Merck Foundation Chief Executive Officer (CEO), Dr. Rasha Kelej Shares Leadership Insights on… African Press Organization16:49 1-Oct-26

Merck's Tulisokibart Meets Endpoints in Hidradenitis Suppurativa Study Zacks15:56 1-Oct-26

Merck to Hold Third-Quarter 2026 Sales and Earnings Conference Call Oct. 29 Business Wire (Press Release)11:47 1-Oct-26

Why Merck (MRK) Dipped More Than Broader Market Today Zacks23:56 30-Sept-26

Merck & Co.’s Phase II For Tulisokibart Is A First For TL1A In Dermatology Scrip Pharma Intelligence19:57 30-Sept-26

Merck Says Investigational Skin Therapy Shows Potential Benzinga19:34 30-Sept-26

2 Outstanding Dividend Stocks to Buy and Hold for a Decade The Motley Fool18:37 30-Sept-26

Merck Is Up 40% This Year… Why Does Our System Keep Marking It Down? Money and Markets18:00 30-Sept-26

Merck and Daiichi Withdraw Small Cell Lung Cancer Drug Bid After FDA Signals Phase 2 Data Fell Short Medical Daily17:14 30-Sept-26

Dr. Rasha Kelej, Chief Executive Officer (CEO) of Merck Foundation Shares Insights on… African Press Organization14:03 30-Sept-26

Merck's Tulisokibart Met Primary and Key Secondary Endpoints in Phase 2b Study in Patients With … Business Wire (Press Release)13:16 30-Sept-26

Schd's Top Sector Bet Is Healthcare at 20.7%. I'm Not Sure What's More Surprising: What It Doesn't Hold, or What It… The Motley Fool12:00 30-Sept-26

NICE backs first systemic therapy for desmoid tumours PharmaTimes11:59 30-Sept-26

2Merck Animal Health Expands SenseHub Dairy Monitoring AgriMarketing08:07 30-Sept-26

Merck pulls antibiotic for multidrug-resistant infections from US market Center for Infectious Disease Research and Policy02:04 30-Sept-26

Merck’s PD-1 Inhibitor Pembrolizumab Subcutaneous Injection Approved in China China Money Network22:30 29-Sept-26

Merck pulls antibiotic from US market Center for Infectious Disease Research and Policy22:20 29-Sept-26

Merck Inks $2.1B Deal With Chinese Biotech to Expand Oncology Pipeline Zacks17:23 29-Sept-26

Pharmalittle: We’re reading about Novo licensing a Chinese obesity pill, Merck pulling an… STAT14:33 29-Sept-26

Ogsiveo recommended by NICE to treat rare soft tissue tumours PMLiVE11:10 29-Sept-26

What Is Merck (MRK) Betting On With Its $2.13 Billion KRAS Deal? Simply Wall St11:04 29-Sept-26

AstraZeneca, Merck, Novo deals boost Chinese biotech as global interest grows South China Morning Post10:02 29-Sept-26

Merck discontinues a crucial antibiotic despite concerns over superbug resistance STAT09:38 29-Sept-26

Mimosas For Merck As Drugmaker Inks Deal With SciBrunch For KRAS Inhibitor Scrip Pharma Intelligence22:18 28-Sept-26

Merck licenses Spr-2015 from China’s Scibrunch in $2B+ deal BioWorld21:52 28-Sept-26

Daiichi, Merck withdraw Bla for B7-H3 ADC in small-cell lung cancer BioWorld21:37 28-Sept-26

Merck, Daiichi Withdraw FDA Filing for Lung Cancer Therapy Zacks18:34 28-Sept-26

FDA Expands Merck's Welireg Label for a New Kidney Cancer Indication Zacks18:14 28-Sept-26

Merck: Ontario Expands Access To Capvaxive Through Publicly Funded Immunization Program RTT News14:24 28-Sept-26

Pharmalittle: We’re reading about GLP-1s becoming lifestyle drugs, a setback for Merck and… STAT14:17 28-Sept-26

Mission Bio Showcases Tapestri Across Drug Discovery and Clinical Development at World CDx… Business Wire (Press Release)14:02 28-Sept-26

Merck Enters into Exclusive Global License Agreement with SciBrunch Therapeutics for SPR2015,… Business Wire (Press Release)11:46 28-Sept-26

B7-H3 ADC Field Opens As Merck & Co. Pulls US Filing Scrip Pharma Intelligence10:55 28-Sept-26

Daiichi, Merck Withdraw U.S. Filing For Lung Cancer Drug Ifinatamab Deruxteca RTT News10:09 28-Sept-26

Merck opens custom bioprocess media center in Daejeon ahead of full site launch Korea Biomedical Review03:36 28-Sept-26

Merck’s Withdrawal Of Recarbrio Takes It Off The Antibiotic Board Scrip Pharma Intelligence23:02 25-Sept-26

Ifinatamab Deruxtecan Biologics License Application for Certain Patients with Previously… Business Wire (Press Release)21:32 25-Sept-26

Merck's Remigromig Meets Main Goal in Diabetic Macular Edema Study Zacks17:25 25-Sept-26

FDA Nod For Welireg-Lenvima Extends Merck’s Push Across The RCC Pathway Scrip Pharma Intelligence14:03 25-Sept-26

Merck's Remigromig Meets Key Goal In Phase 2b/3 Brunello Study In Diabetic Macular Edema RTT News08:50 25-Sept-26

Dme red flag in Merck Brunello phase III? Surrozen finishes rich BioWorld22:21 24-Sept-26

Merck’s Wnt Agonist Is Efficacious As New Mechanism For Eye Disease Scrip Pharma Intelligence19:45 24-Sept-26

Merck Says Investigational Diabetes-Related Blindness Drug at Par With Roche’s Medicine Benzinga18:44 24-Sept-26

Trebellar Raises $18M Series A to Bring AI to Corporate Real Estate Management Business Wire (Press Release)16:01 24-Sept-26

Merck's Remigromig Meets Phase 3 Goal In Diabetic Macular Edema Study RTT News12:40 24-Sept-26

BigHat Biosciences Announces $75 Million Series C Financing to Advance AI-Designed Therapeutics … Business Wire (Press Release)12:06 24-Sept-26

Merck’s Remigromig, a Tri-specific Agonist of the Wingless-related Integration Site (Wnt)… Business Wire (Press Release)11:47 24-Sept-26

Merck (MRK) Declines More Than Market: Some Information for Investors Zacks23:53 23-Sept-26

Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, Germany PR Newswire (Press Release)14:20 23-Sept-26

Merck Manuals Details What Patients Need to Know About Inflammatory Bowel Disease PR Newswire (Press Release)14:01 23-Sept-26

Computational Chemistry and AI in Chemistry Conference at Merck in Darmstadt Merck Group (Press Release)00:12 23-Sept-26

Wall Street Analysts Think Merck (MRK) Is a Good Investment: Is It? Zacks15:33 22-Sept-26

Merck sued with former LOT Network/Canon patent by biotech NPE IAM14:49 22-Sept-26

Merck Foundation in Partnership with African and Asian First Ladies Invites Applications for… African Press Organization14:26 22-Sept-26

Merck Gets CHMP Backing for Keytruda-Padcev Combo in Bladder Cancer Zacks17:36 21-Sept-26

Merck’s Keytruda Qlex™ (pembrolizumab and berahyaluronidase alfa-pmph) Approved in Japan for… Business Wire (Press Release)11:46 21-Sept-26

Merck raises awareness of children’s growth on International Children’s Growth Awareness Day Korea Biomedical Review03:13 21-Sept-26

Merck Advances European Regulatory Approval For Keytruda Combination In Bladder Cancer Benzinga17:47 18-Sept-26

Dr. Rasha Kelej Shares Leadership Lessons on Building Sustainable Cancer Care Capacity Across Africa The Hindu Business Line13:07 18-Sept-26

Merck Receives Positive EU Chmp Opinion for Keytruda® (pembrolizumab) Plus Padcev® (enfortumab… Business Wire (Press Release)11:56 18-Sept-26

Merck Launches Your Hive of Whole Health to Support Whole Person Care for People Living With HIV Business Wire (Press Release)11:46 18-Sept-26

BioNTech Threw in the Towel on Its Colorectal Cancer Vaccine Trial. Should Investors Be Worried? The Motley Fool10:00 18-Sept-26

Merck (MRK) Outperforms Broader Market: What You Need to Know Zacks23:56 17-Sept-26

Feature — Top Intelligence Provider for Investment Banks and Corporate Law Firms Predicts Signals for Deal Makers:… National Law Review16:16 17-Sept-26

Big Tech now spends almost 3x more on R&D than Big Pharma R&D World21:02 16-Sept-26

Keytruda Qlex™ Updates: PTAB Finds Halozyme ’520 PH20 Patent Unpatentable and Institutes Three IPRs JD Supra17:46 16-Sept-26

Merck Foundation Chief Executive Officer (CEO), Dr. Rasha Kelej Publishes New Leadership… African Press Organization15:52 16-Sept-26

Breakfast News: Why Merck Should Buy Moderna The Motley Fool12:53 16-Sept-26

How Dr. Rasha Kelej is Transforming Fertility Care and Breaking Infertility Stigma through… African Press Organization15:46 15-Sept-26

view more headlines

15 Oct 21:03

Merck & Co News

NewsNow aims to be the world's most accurate and comprehensive aggregator of Merck & Co news, covering the latest MSD share price, Merck Sharp & Dohme company announcements, product trials, pharmaceutical news and more from the best online publications. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication.

Publication filters

Sorry, no headlines or news topics were found. Please try different keywords.